Margaretha A Skowron

11PUBLICATIONS
52CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 02, 2026
The Functional Role and Molecular Characterization of the Therapeutic Target CLDN6 in Germ Cell Tumors.

Jule Zwick, Margaretha A Skowron, Gereon Poschmann

|May 31, 2023
CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners.

Christian Söhngen, David J Thomas, Margaretha A Skowron

|Mar 29, 2023
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options.

Margaretha A Skowron, Mara Kotthoff, Felix Bremmer

|Aug 24, 2022
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies.

Aaron Burmeister, Alexa Stephan, Leandro A Alves Avelar

|Jul 11, 2022
Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level.

Margaretha A Skowron, Katharina Eul, Alexa Stephan

|Jul 22, 2021
The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas.

Margaretha A Skowron, Teresa K Becker, Lukas Kurz

Pageof 2

Frequent Collaborators

8 joint publications

Daniel Nettersheim

5 joint publications

Patrick Petzsch

4 joint publications

Günter Niegisch

4 joint publications

Kai Stühler